Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Fusen Pharmaceutical Co., Ltd. ( (HK:1652) ) has provided an announcement.
Fusen Pharmaceutical Co., Ltd. has announced a significant change in its shareholding structure following the passing of Mr. Cao, the former chairman and investment manager of Fusen Trust. The Vesting Arrangement has transferred control of the voting rights of Fusen Trust Shares to Mr. Cao Zhiming, increasing his voting rights to 45.29% of the total issued shares. This change has triggered a potential requirement for a mandatory general offer under the Takeovers Code, but Mr. Cao Zhiming has obtained a waiver from this obligation.
More about Fusen Pharmaceutical Co., Ltd.
Average Trading Volume: 352,155
Technical Sentiment Signal: Sell
Current Market Cap: HK$286.7M
See more insights into 1652 stock on TipRanks’ Stock Analysis page.